CIK 0001818794 · Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364883909
- Phone
- (781) 786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- 144 Insider Sale of Securities
- 4 Planned sale Chief Commercial Officer sold 148 shares at $14.90 ($2,205)
- 4 Planned sale Chief Medical Officer sold 904 shares at $14.90 ($13,470)
- 4 Planned sale CEO & President sold 2,732 shares at $14.90 ($40,707)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Grant or award CEO & President acquired 180,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 85,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 65,000 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 424B5 Offering Prospectus
Page 9 of 40 · 796 filings